FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
VERU DENNISON T
  2. Issuer Name and Ticker or Trading Symbol
Brickell Biotech, Inc. [BBI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O BRICKELL BIOTECH, INC., 5777 CENTRAL AVENUE, SUITE 102
3. Date of Earliest Transaction (Month/Day/Year)
02/14/2020
(Street)

BOULDER, CO 80301
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock               7,230 D  
Common Stock               950,905 I By Self due to Control over the Entity that holds Shares

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $ 10.36             08/30/2019 08/30/2029 Common Stock 3,316   3,316 D  
Stock Options $ 12.17             04/22/2015 04/22/2025 Common Stock 8,630   8,630 I By Self due to Control of Entity that Holds Options
Stock Options $ 12.17             12/15/2016 12/15/2026 Common Stock 3,452   3,452 I By Self due to Control of Entity that Holds Options
Stock Options $ 16.45             12/15/2019 12/15/2029 Common Stock 5,178   5,178 I By Self due to Control of Entity that Holds Options
Stock Options $ 4.76             08/30/2020 08/30/2029 Common Stock 34,521   34,521 I By Self due to Control of Entity that Holds Options
Restricted Stock Units $ 1.16 02/14/2020   A   2,167   02/14/2020 02/13/2030 Common Stock 2,167 $ 1.16 2,167 I By Self due to Control of Entity that Holds RSUs
Stock Options $ 1.16 02/14/2020   A   9,483   02/14/2020 02/13/2030 Common Stock 9,483 $ 1.16 9,483 I By Self due to Control of Entity that Holds Options

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
VERU DENNISON T
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER, CO 80301
  X      

Signatures

 /s/ Dennison T. Veru   02/19/2020
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.